ZNTL

1.3600.00%
RJ

Robert J. DiVasto

Chief Technical Officer

Mr. Robert J. DiVasto, also known as Bob, P.E., is Chief Technical Officer since Feb 2026 and was Senior Vice President of Technical Operations of Zentalis Pharmaceuticals, Inc. from 2025 to Feb 2026 and served as Senior Vice President of Manufacturing and Supply since 2023 until May 2023 and has been Vice President of Supply Operations of Cadence Pharmaceuticals Inc. since April 6, 2009. From October 2007 to April 2009, he served as an independent consultant to the life sciences industry, focused on operations, facilities and supply chain management. From May 2003 to October 2007, he served in various positions of increasing responsibility at Valeant Pharmaceuticals International, including as Vice President, Global Manufacturing and Supply from March 2005 to October 2007, as Vice President, European Supply from January 2004 to March 2005 and as Vice President, Global Strategy, Logistics and Engineering from May 2003 to January 2004. Previously, he served as Director, Global Planning and Analysis for the Global Manufacturing and Supply Division of GlaxoSmithKline plc, a global pharmaceutical company, from January 2001 to May 2003 and as Senior Project Director, Cornwallis Campus Capital Projects, for GlaxoSmithKline (formerly, Glaxo Wellcome, plc) from August 1991 to January 2001. From January 1981 to August 1991, he also served as Chief Engineer, Manufacturing and Process Engineering at The Sigel Group, a bio/pharmaceutical engineering and architectural firm. He holds an A.E. in Architectural Engineering from Pennsylvania State University, a B.S. in Environmental Engineering from Temple University and a Masters of Studies in Manufacturing Leadership from the University of Cambridge and is a licensed Professional Engineer in the State of Pennsylvania. Mr. DiVasto has B.S. in Environmental Engineering from Temple University. Mr. DiVasto has Master's in Manufacturing from University of Cambridge.

Positions